Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline

PURPOSE: In the Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management (WISDOM) trial, inhaled corticosteroid (ICS) withdrawal in patients with chronic obstructive pulmonary disease receiving triple therapy (long-acting β(2)-agonist+long-acting muscarinic antagonist+ICS) did not c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Gary T, Shaikh, Asif, Tetzlaff, Kay, Mueller, Achim, Magnussen, Helgo, Watz, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667507/
https://www.ncbi.nlm.nih.gov/pubmed/33204084
http://dx.doi.org/10.2147/COPD.S237408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667507/
https://www.ncbi.nlm.nih.gov/pubmed/33204084
http://dx.doi.org/10.2147/COPD.S237408

Ejemplares similares